CASTLE BIOSCIENCES INC
For the period ended May 6, 2026. Filed May 6, 2026.
View on SEC.govAbout this filing
A notice of a major event between regular reports, such as results, a deal or a change of executives. It is often the first formal record of the news.
May 6, 2026 · Filed May 6, 2026
Use the contents to explore the available documents and sections.
CSTL$32.52-4.9%Stored close · as of Nov 6, 2026
Contents
EX-99.1 · (in thousands, except per share data)
(in thousands, except per share data)
| Three Months EndedMarch 31, | ||
|---|---|---|
| 2026 | 2025 | |
| NET REVENUES | $83,679 | $87,988 |
| OPERATING EXPENSES | ||
| Cost of sales (exclusive of amortization of acquired intangible assets) | 20,533 | 16,383 |
| Research and development | 14,428 | 12,588 |
| Selling, general and administrative | 64,899 | 58,620 |
| Amortization of acquired intangible assets | 2,226 | 28,325 |
| Total operating expenses, net | 102,086 | 115,916 |
| Operating loss | (18,407) | (27,928) |
| Interest income | 2,545 | 3,099 |
| Net gains (losses) on equity securities | 2,022 | (1,425) |
| Interest expense | (134) | (17) |
| Other loss | (439) | — |
| Loss before income taxes | (14,413) | (26,271) |
| Income tax expense (benefit) | 109 | (423) |
| Net loss | $(14,522) | $(25,848) |
| Loss per share, basic and diluted | $(0.49) | $(0.90) |
| Weighted-average shares outstanding, basic and diluted | 29,889 | 28,609 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.